Nanospectra Biosciences

Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.

Nanospectra Biosciences, Inc., a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences, Inc. was founded in 2002 and is based in Houston, Texas.